tiprankstipranks
Trending News
More News >
Argenx Se: Strong Growth Prospects and Attractive Buying Opportunity Amid Vyvgart Expansion and Upcoming Catalysts
PremiumRatingsArgenx Se: Strong Growth Prospects and Attractive Buying Opportunity Amid Vyvgart Expansion and Upcoming Catalysts
19d ago
Argenx price target lowered to $699 from $701 at Citizens JMP
Premium
The Fly
Argenx price target lowered to $699 from $701 at Citizens JMP
26d ago
Argenx upgraded to Outperform from Neutral at Baird
Premium
The Fly
Argenx upgraded to Outperform from Neutral at Baird
27d ago
Argenx price target lowered to $1,065 from $1,100 at Guggenheim
PremiumThe FlyArgenx price target lowered to $1,065 from $1,100 at Guggenheim
1M ago
Buy Recommendation for Argenx: Strong Vyvgart Sales Growth and Promising PFS Launch Drive Confidence
Premium
Ratings
Buy Recommendation for Argenx: Strong Vyvgart Sales Growth and Promising PFS Launch Drive Confidence
1M ago
Argenx price target raised to $803 from $796 at Citi
Premium
The Fly
Argenx price target raised to $803 from $796 at Citi
1M ago
Argenx announces CHMP opinion recommending approval of Vyvgart 1000mg
PremiumThe FlyArgenx announces CHMP opinion recommending approval of Vyvgart 1000mg
1M ago
Argenx Se’s Revenue Growth Potential Boosted by Vyvgart Hytrulo’s Market Impact and Increased Treatment Cycles
Premium
Ratings
Argenx Se’s Revenue Growth Potential Boosted by Vyvgart Hytrulo’s Market Impact and Increased Treatment Cycles
2M ago
Argenx price target lowered to EUR 680 from EUR 736 at BofA
Premium
The Fly
Argenx price target lowered to EUR 680 from EUR 736 at BofA
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100